Title: Achieving Minimal Residual Disease (MRD) Negativity during the Disease Course in relapsed/refractory Multiple Myeloma (RRMM): Implications for Treatment and Transplant Strategies

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Ali Awada, Amjad Alguraan, Ali Tarhini, Ali Tarhini, Yara Shatnawi, Haritha Gandicheruvu, Katia Kautaich, Faiz Anwer

DOI: 10.1016/j.jtct.2025.12.641

Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Multiple Sclerosis Research Studies Chronic Lymphocytic Leukemia Research